| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.15 | 0.005 |
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.13 | 0.006 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | 0.15 | 0.006 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | -0.089 | 0.007 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.007 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.13 | 0.007 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.16 | 0.008 |
| mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.008 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.093 | 0.008 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.19 | 0.008 |